Literature DB >> 11733031

Cell culture analysis of the regulatory frameshift event required for the expression of mammalian antizymes.

M T Howard1, B H Shirts, J Zhou, C L Carlson, S Matsufuji, R F Gesteland, R S Weeks, J F Atkins.   

Abstract

BACKGROUND: Antizyme is a critical regulator of cellular polyamine levels due to its effect on polyamine transport and its ability to target ornithine decarboxylase for degradation. Antizyme expression is autoregulatory, through dependence on an unusual +1 translational frameshift mechanism that responds to polyamine levels.
RESULTS: HEK293 cells were depleted of polyamines by treatment with an ornithine decarboxylase inhibitor, difluoromethylornithine (DFMO), and grown in the presence or absence of exogenous polyamines prior to the analysis of ribosomal frameshifting levels. Results obtained using an optimized dual luciferase assay system reveal a 10-fold dynamic range of frameshifting, which correlates positively with polyamine addition. Polyamine addition to cells, which have not been pre-treated with DFMO, also resulted in an increase in antizyme frameshifting but to a lesser degree (1.3 to 1.5-fold). In addition, the constructs with the 3' deletion were more responsive to stimulation by polyamine addition than those with the 5' deletion.
CONCLUSIONS: The observed regulation of antizyme frameshifting demonstrates the efficiency of a polyamine homeostatic mechanism, and illustrates the utility of a quantifiable cell-based assay for the analysis of polyamines or their analogues on translational frameshifting.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733031     DOI: 10.1046/j.1365-2443.2001.00477.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  16 in total

1.  Evolutionary specialization of recoding: frameshifting in the expression of S. cerevisiae antizyme mRNA is via an atypical antizyme shift site but is still +1.

Authors:  Ivaylo P Ivanov; Raymond F Gesteland; John F Atkins
Journal:  RNA       Date:  2006-01-23       Impact factor: 4.942

2.  uORFs with unusual translational start codons autoregulate expression of eukaryotic ornithine decarboxylase homologs.

Authors:  Ivaylo P Ivanov; Gary Loughran; John F Atkins
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-14       Impact factor: 11.205

3.  A homogeneous cell-based bicistronic fluorescence assay for high-throughput identification of drugs that perturb viral gene recoding and read-through of nonsense stop codons.

Authors:  Tony S Cardno; Elizabeth S Poole; Suneeth F Mathew; Ryan Graves; Warren P Tate
Journal:  RNA       Date:  2009-06-17       Impact factor: 4.942

Review 4.  Current status of the polyamine research field.

Authors:  Anthony E Pegg; Robert A Casero
Journal:  Methods Mol Biol       Date:  2011

Review 5.  Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use.

Authors:  John F Atkins; Gary Loughran; Pramod R Bhatt; Andrew E Firth; Pavel V Baranov
Journal:  Nucleic Acids Res       Date:  2016-07-19       Impact factor: 16.971

6.  Ornithine decarboxylase antizyme Oaz3 modulates protein phosphatase activity.

Authors:  Yibing Ruan; Min Cheng; Young Ou; Richard Oko; Frans A van der Hoorn
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

Review 7.  Roles of polyamines in translation.

Authors:  Thomas E Dever; Ivaylo P Ivanov
Journal:  J Biol Chem       Date:  2018-10-15       Impact factor: 5.157

8.  Agmatine (decarboxylated arginine), a modulator of liver cell homeostasis and proliferation.

Authors:  Bettina Kribben; Jörg Heller; Jonel Trebicka; Tilman Sauerbruch; Michael Brüss; Manfred Göthert; Gerhard J Molderings
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-15       Impact factor: 3.000

Review 9.  Antizyme and antizyme inhibitor, a regulatory tango.

Authors:  Chaim Kahana
Journal:  Cell Mol Life Sci       Date:  2009-04-28       Impact factor: 9.261

10.  Interactions between UPF1, eRFs, PABP and the exon junction complex suggest an integrated model for mammalian NMD pathways.

Authors:  Pavel V Ivanov; Niels H Gehring; Joachim B Kunz; Matthias W Hentze; Andreas E Kulozik
Journal:  EMBO J       Date:  2008-02-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.